Annual EBITDA
-$15.44 M
+$9.84 M+38.91%
December 31, 2023
Summary
- As of February 26, 2025, BIOL annual EBITDA is -$15.44 million, with the most recent change of +$9.84 million (+38.91%) on December 31, 2023.
- During the last 3 years, BIOL annual EBITDA has fallen by -$1.60 million (-11.55%).
Performance
BIOL EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBITDA
-$97.00 K
+$1.45 M+93.71%
September 30, 2024
Summary
- As of February 26, 2025, BIOL quarterly EBITDA is -$97.00 thousand, with the most recent change of +$1.45 million (+93.71%) on September 30, 2024.
- Over the past year, BIOL quarterly EBITDA has increased by +$3.32 million (+97.16%).
Performance
BIOL Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBITDA
-$10.90 M
+$3.32 M+23.35%
September 30, 2024
Summary
- As of February 26, 2025, BIOL TTM EBITDA is -$10.90 million, with the most recent change of +$3.32 million (+23.35%) on September 30, 2024.
- Over the past year, BIOL TTM EBITDA has increased by +$8.66 million (+44.27%).
Performance
BIOL TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
BIOL EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +38.9% | +97.2% | +44.3% |
| 3 y3 years | -11.6% | +97.2% | +44.3% |
| 5 y5 years | +22.8% | +97.2% | +44.3% |
BIOL EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | +14.6% | +63.7% | at high | +8338.1% | at high | +140.4% |
| 5 y | 5-year | +14.6% | +63.7% | -115.3% | +8338.1% | at high | +140.4% |
| alltime | all time | -310.8% | +63.7% | -103.6% | +9449.5% | -241.5% | +140.4% |
BIOLASE EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$97.00 K(-93.7%) | -$10.90 M(-23.3%) |
| Jun 2024 | - | -$1.54 M(-70.3%) | -$14.21 M(-8.3%) |
| Mar 2024 | - | -$5.18 M(+27.3%) | -$15.50 M(+0.4%) |
| Dec 2023 | -$15.44 M(-38.9%) | -$4.07 M(+19.2%) | -$15.44 M(-21.0%) |
| Sep 2023 | - | -$3.42 M(+20.7%) | -$19.55 M(-18.5%) |
| Jun 2023 | - | -$2.83 M(-44.7%) | -$24.00 M(-8.4%) |
| Mar 2023 | - | -$5.12 M(-37.4%) | -$26.19 M(+3.6%) |
| Dec 2022 | -$25.28 M(+87.7%) | -$8.19 M(+4.2%) | -$25.28 M(+16.6%) |
| Sep 2022 | - | -$7.86 M(+56.3%) | -$21.69 M(+32.1%) |
| Jun 2022 | - | -$5.03 M(+19.5%) | -$16.42 M(+42.8%) |
| Mar 2022 | - | -$4.21 M(-8.3%) | -$11.50 M(-14.6%) |
| Dec 2021 | -$13.47 M(-2.7%) | -$4.59 M(+77.4%) | -$13.47 M(-6.2%) |
| Sep 2021 | - | -$2.59 M(+2274.3%) | -$14.36 M(+28.9%) |
| Jun 2021 | - | -$109.00 K(-98.2%) | -$11.14 M(-24.4%) |
| Mar 2021 | - | -$6.18 M(+12.7%) | -$14.74 M(+6.7%) |
| Dec 2020 | -$13.84 M(-6.2%) | -$5.49 M(-965.3%) | -$13.82 M(+23.3%) |
| Sep 2020 | - | $634.00 K(-117.1%) | -$11.21 M(-32.2%) |
| Jun 2020 | - | -$3.71 M(-29.5%) | -$16.52 M(+4.0%) |
| Mar 2020 | - | -$5.26 M(+83.0%) | -$15.88 M(+7.5%) |
| Dec 2019 | -$14.76 M(-26.2%) | -$2.87 M(-38.6%) | -$14.77 M(-18.8%) |
| Sep 2019 | - | -$4.68 M(+52.3%) | -$18.18 M(+1.7%) |
| Jun 2019 | - | -$3.07 M(-26.0%) | -$17.88 M(-8.0%) |
| Mar 2019 | - | -$4.15 M(-34.0%) | -$19.43 M(-2.8%) |
| Dec 2018 | -$20.00 M(+22.5%) | -$6.28 M(+43.5%) | -$20.00 M(+13.5%) |
| Sep 2018 | - | -$4.38 M(-5.2%) | -$17.61 M(-0.4%) |
| Jun 2018 | - | -$4.62 M(-2.0%) | -$17.68 M(+2.5%) |
| Mar 2018 | - | -$4.71 M(+20.8%) | -$17.26 M(+5.7%) |
| Dec 2017 | -$16.33 M(+17.4%) | -$3.90 M(-12.4%) | -$16.33 M(+0.4%) |
| Sep 2017 | - | -$4.45 M(+6.2%) | -$16.27 M(+10.8%) |
| Jun 2017 | - | -$4.19 M(+10.8%) | -$14.68 M(+8.0%) |
| Mar 2017 | - | -$3.79 M(-1.5%) | -$13.60 M(-2.3%) |
| Dec 2016 | -$13.91 M(-29.6%) | -$3.84 M(+34.3%) | -$13.91 M(+15.4%) |
| Sep 2016 | - | -$2.86 M(-8.1%) | -$12.06 M(-15.6%) |
| Jun 2016 | - | -$3.11 M(-24.1%) | -$14.28 M(-20.8%) |
| Mar 2016 | - | -$4.10 M(+106.7%) | -$18.04 M(-8.8%) |
| Dec 2015 | -$19.77 M(+14.6%) | -$1.98 M(-61.0%) | -$19.77 M(-7.1%) |
| Sep 2015 | - | -$5.09 M(-25.9%) | -$21.27 M(+9.4%) |
| Jun 2015 | - | -$6.86 M(+17.7%) | -$19.43 M(+4.4%) |
| Mar 2015 | - | -$5.83 M(+67.3%) | -$18.62 M(+8.0%) |
| Dec 2014 | -$17.25 M(+65.9%) | -$3.49 M(+7.2%) | -$17.25 M(+10.9%) |
| Sep 2014 | - | -$3.25 M(-46.2%) | -$15.55 M(-2.8%) |
| Jun 2014 | - | -$6.05 M(+35.7%) | -$16.00 M(+32.4%) |
| Mar 2014 | - | -$4.46 M(+149.1%) | -$12.08 M(+16.2%) |
| Dec 2013 | -$10.39 M(+374.0%) | -$1.79 M(-51.7%) | -$10.39 M(+42.2%) |
| Sep 2013 | - | -$3.70 M(+73.9%) | -$7.31 M(+87.6%) |
| Jun 2013 | - | -$2.13 M(-23.1%) | -$3.90 M(+13.0%) |
| Mar 2013 | - | -$2.77 M(-314.1%) | -$3.45 M(+57.3%) |
| Dec 2012 | -$2.19 M(-35.4%) | $1.29 M(-546.2%) | -$2.19 M(-59.2%) |
| Sep 2012 | - | -$290.00 K(-82.8%) | -$5.38 M(-7.8%) |
| Jun 2012 | - | -$1.68 M(+11.2%) | -$5.83 M(+24.1%) |
| Mar 2012 | - | -$1.51 M(-19.8%) | -$4.70 M(+29.6%) |
| Dec 2011 | -$3.40 M(-67.7%) | -$1.89 M(+154.1%) | -$3.62 M(+209.8%) |
| Sep 2011 | - | -$743.00 K(+35.1%) | -$1.17 M(-56.8%) |
| Jun 2011 | - | -$550.00 K(+24.7%) | -$2.71 M(-54.7%) |
| Mar 2011 | - | -$441.00 K(-178.1%) | -$5.98 M(-43.2%) |
| Dec 2010 | -$10.53 M(+688.9%) | $565.00 K(-124.8%) | -$10.53 M(-13.5%) |
| Sep 2010 | - | -$2.28 M(-40.3%) | -$12.18 M(+40.3%) |
| Jun 2010 | - | -$3.82 M(-23.4%) | -$8.68 M(+307.9%) |
| Mar 2010 | - | -$4.99 M(+362.1%) | -$2.13 M(+59.4%) |
| Dec 2009 | -$1.33 M(-80.8%) | -$1.08 M(-188.9%) | -$1.33 M(-73.2%) |
| Sep 2009 | - | $1.22 M(-55.5%) | -$4.98 M(-50.8%) |
| Jun 2009 | - | $2.73 M(-165.0%) | -$10.12 M(-15.5%) |
| Mar 2009 | - | -$4.20 M(-11.2%) | -$11.98 M(+52.3%) |
| Dec 2008 | -$6.94 M | -$4.73 M(+20.4%) | -$7.87 M(+49.3%) |
| Sep 2008 | - | -$3.92 M(-553.8%) | -$5.27 M(+18.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2008 | - | $865.00 K(-1181.3%) | -$4.46 M(-22.7%) |
| Mar 2008 | - | -$80.00 K(-96.2%) | -$5.77 M(-18.5%) |
| Dec 2007 | -$7.08 M(+178.9%) | -$2.13 M(-31.5%) | -$7.08 M(+117.6%) |
| Sep 2007 | - | -$3.11 M(+596.0%) | -$3.25 M(+294.5%) |
| Jun 2007 | - | -$447.00 K(-67.8%) | -$824.00 K(-62.2%) |
| Mar 2007 | - | -$1.39 M(-181.9%) | -$2.18 M(-14.1%) |
| Dec 2006 | -$2.54 M(-83.9%) | $1.69 M(-347.7%) | -$2.54 M(-47.4%) |
| Sep 2006 | - | -$684.00 K(-62.0%) | -$4.82 M(-46.6%) |
| Jun 2006 | - | -$1.80 M(+3.3%) | -$9.02 M(-33.0%) |
| Mar 2006 | - | -$1.75 M(+196.3%) | -$13.47 M(-14.5%) |
| Dec 2005 | -$15.75 M(+81.8%) | -$589.00 K(-87.9%) | -$15.75 M(-35.5%) |
| Sep 2005 | - | -$4.88 M(-21.9%) | -$24.42 M(+13.4%) |
| Jun 2005 | - | -$6.25 M(+55.5%) | -$21.53 M(+54.7%) |
| Mar 2005 | - | -$4.02 M(-56.6%) | -$13.92 M(+60.6%) |
| Dec 2004 | -$8.66 M(-218.3%) | -$9.26 M(+364.8%) | -$8.66 M(-387.5%) |
| Sep 2004 | - | -$1.99 M(-246.4%) | $3.01 M(-60.9%) |
| Jun 2004 | - | $1.36 M(+10.6%) | $7.70 M(+1.2%) |
| Mar 2004 | - | $1.23 M(-49.0%) | $7.61 M(+3.8%) |
| Dec 2003 | $7.33 M(+341.9%) | $2.42 M(-10.3%) | $7.33 M(+38.1%) |
| Sep 2003 | - | $2.69 M(+112.3%) | $5.30 M(+74.0%) |
| Jun 2003 | - | $1.27 M(+33.3%) | $3.05 M(+26.5%) |
| Mar 2003 | - | $951.00 K(+142.0%) | $2.41 M(+47.7%) |
| Dec 2002 | $1.66 M(-267.0%) | $393.00 K(-10.1%) | $1.63 M(+89.3%) |
| Sep 2002 | - | $437.00 K(-30.5%) | $862.00 K(+59.5%) |
| Jun 2002 | - | $629.00 K(+263.6%) | $540.50 K(-406.2%) |
| Mar 2002 | - | $173.00 K(-145.9%) | -$176.50 K(-82.2%) |
| Dec 2001 | -$993.00 K(-71.4%) | -$377.00 K(-426.4%) | -$992.90 K(-13.0%) |
| Sep 2001 | - | $115.50 K(-231.3%) | -$1.14 M(-51.6%) |
| Jun 2001 | - | -$88.00 K(-86.3%) | -$2.36 M(-24.5%) |
| Mar 2001 | - | -$643.40 K(+22.5%) | -$3.12 M(-10.0%) |
| Dec 2000 | -$3.47 M(-25.2%) | -$525.40 K(-52.2%) | -$3.47 M(-30.4%) |
| Sep 2000 | - | -$1.10 M(+29.0%) | -$4.98 M(+6.7%) |
| Jun 2000 | - | -$852.50 K(-13.9%) | -$4.67 M(-6.8%) |
| Mar 2000 | - | -$990.10 K(-51.5%) | -$5.01 M(+6.1%) |
| Dec 1999 | -$4.64 M(-7.3%) | -$2.04 M(+159.2%) | -$4.72 M(+10.3%) |
| Sep 1999 | - | -$787.20 K(-34.1%) | -$4.28 M(-12.5%) |
| Jun 1999 | - | -$1.19 M(+70.5%) | -$4.89 M(-0.1%) |
| Mar 1999 | - | -$700.00 K(-56.3%) | -$4.90 M(-2.0%) |
| Dec 1998 | -$5.00 M(+78.6%) | -$1.60 M(+14.3%) | -$5.00 M(+19.0%) |
| Sep 1998 | - | -$1.40 M(+16.7%) | -$4.20 M(+27.3%) |
| Jun 1998 | - | -$1.20 M(+50.0%) | -$3.30 M(+13.8%) |
| Mar 1998 | - | -$800.00 K(0.0%) | -$2.90 M(0.0%) |
| Dec 1997 | -$2.80 M(+16.7%) | -$800.00 K(+60.0%) | -$2.90 M(0.0%) |
| Sep 1997 | - | -$500.00 K(-37.5%) | -$2.90 M(-3.3%) |
| Jun 1997 | - | -$800.00 K(0.0%) | -$3.00 M(+15.4%) |
| Mar 1997 | - | -$800.00 K(0.0%) | -$2.60 M(+8.3%) |
| Dec 1996 | -$2.40 M(+41.2%) | -$800.00 K(+33.3%) | -$2.40 M(+26.3%) |
| Sep 1996 | - | -$600.00 K(+50.0%) | -$1.90 M(+26.7%) |
| Jun 1996 | - | -$400.00 K(-33.3%) | -$1.50 M(0.0%) |
| Mar 1996 | - | -$600.00 K(+100.0%) | -$1.50 M(-6.3%) |
| Dec 1995 | -$1.70 M(-51.4%) | -$300.00 K(+50.0%) | -$1.60 M(-40.7%) |
| Sep 1995 | - | -$200.00 K(-50.0%) | -$2.70 M(-18.2%) |
| Jun 1995 | - | -$400.00 K(-42.9%) | -$3.30 M(0.0%) |
| Mar 1995 | - | -$700.00 K(-50.0%) | -$3.30 M(+37.5%) |
| Dec 1994 | -$3.50 M(-49.3%) | -$1.40 M(+75.0%) | -$2.40 M(-27.3%) |
| Sep 1994 | - | -$800.00 K(+100.0%) | -$3.30 M(-15.4%) |
| Jun 1994 | - | -$400.00 K(-300.0%) | -$3.90 M(-25.0%) |
| Mar 1994 | - | $200.00 K(-108.7%) | -$5.20 M(-23.5%) |
| Dec 1993 | -$6.90 M(+30.2%) | -$2.30 M(+64.3%) | -$6.80 M(0.0%) |
| Sep 1993 | - | -$1.40 M(-17.6%) | -$6.80 M(+6.3%) |
| Jun 1993 | - | -$1.70 M(+21.4%) | -$6.40 M(+8.5%) |
| Mar 1993 | - | -$1.40 M(-39.1%) | -$5.90 M(+90.3%) |
| Dec 1992 | -$5.30 M | -$2.30 M(+130.0%) | -$3.10 M(+287.5%) |
| Sep 1992 | - | -$1.00 M(-16.7%) | -$800.00 K(-500.0%) |
| Jun 1992 | - | -$1.20 M(-185.7%) | $200.00 K(-85.7%) |
| Mar 1992 | - | $1.40 M | $1.40 M |
FAQ
- What is BIOLASE annual EBITDA?
- What is the all time high annual EBITDA for BIOLASE?
- What is BIOLASE annual EBITDA year-on-year change?
- What is BIOLASE quarterly EBITDA?
- What is the all time high quarterly EBITDA for BIOLASE?
- What is BIOLASE quarterly EBITDA year-on-year change?
- What is BIOLASE TTM EBITDA?
- What is the all time high TTM EBITDA for BIOLASE?
- What is BIOLASE TTM EBITDA year-on-year change?
What is BIOLASE annual EBITDA?
The current annual EBITDA of BIOL is -$15.44 M
What is the all time high annual EBITDA for BIOLASE?
BIOLASE all-time high annual EBITDA is $7.33 M
What is BIOLASE annual EBITDA year-on-year change?
Over the past year, BIOL annual EBITDA has changed by +$9.84 M (+38.91%)
What is BIOLASE quarterly EBITDA?
The current quarterly EBITDA of BIOL is -$97.00 K
What is the all time high quarterly EBITDA for BIOLASE?
BIOLASE all-time high quarterly EBITDA is $2.73 M
What is BIOLASE quarterly EBITDA year-on-year change?
Over the past year, BIOL quarterly EBITDA has changed by +$3.32 M (+97.16%)
What is BIOLASE TTM EBITDA?
The current TTM EBITDA of BIOL is -$10.90 M
What is the all time high TTM EBITDA for BIOLASE?
BIOLASE all-time high TTM EBITDA is $7.70 M
What is BIOLASE TTM EBITDA year-on-year change?
Over the past year, BIOL TTM EBITDA has changed by +$8.66 M (+44.27%)